Share This Page
Drug Price Trends for NDC 42794-0003
✉ Email this page to a colleague
Average Pharmacy Cost for 42794-0003
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ADEFOVIR DIPIVOXIL 10 MG TAB | 42794-0003-08 | 23.69832 | EACH | 2025-12-17 |
| ADEFOVIR DIPIVOXIL 10 MG TAB | 42794-0003-08 | 24.45817 | EACH | 2025-11-19 |
| ADEFOVIR DIPIVOXIL 10 MG TAB | 42794-0003-08 | 24.71382 | EACH | 2025-10-22 |
| ADEFOVIR DIPIVOXIL 10 MG TAB | 42794-0003-08 | 24.71382 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42794-0003
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 42794-0003
Introduction
The pharmaceutical landscape is a dynamic and competitive environment, influenced by regulatory developments, patent statuses, manufacturing trends, and market demand. This analysis examines the market and price trajectory for the drug identified by NDC 42794-0003, offering insights into its current positioning, potential growth factors, and future pricing strategies.
Product Overview
NDC 42794-0003 pertains to a specific formulation within the pharmaceutical market—presumably a branded or generic medication. Precise details regarding its active ingredient, indication, and formulation are essential to contextualize market assessments accurately. For this analysis, we assume the drug addresses a prevalent condition with established therapeutic efficacy, and it holds either a patent-protected status or is nearing exclusivity expiration.
Current Market Landscape
Market Size and Demand Dynamics
The demand for pharmaceuticals like NDC 42794-0003 hinges on several factors:
-
Prevalence of Indication: If targeted at a common disease such as hypertension, diabetes, or depression, the market size remains substantial. For instance, drugs for diabetes management, like insulin or oral hypoglycemics, serve millions globally.
-
Treatment Adoption: Physician prescribing patterns, patient adherence, and formularies influence uptake. Drugs with proven efficacy, safety profiles, and favorable side-effect profiles typically achieve higher adoption.
-
Competitive Environment: Presence of generics, biosimilars, or newer therapeutic agents impacts market share. A patent expiry could open the market to lower-cost competitors, pressuring prices.
Regulatory and Patent Status
-
Patent Life: A patent extension can sustain higher prices. Conversely, nearing expiry invites generic competition, intensifying price competition.
-
Regulatory Approvals: FDA or EMA approvals broaden market access. Recent approvals, supplemental indications, or labeling changes can catalyze market growth.
Pricing Trends and Historical Data
Current Pricing Landscape
Market retail and wholesale prices for NDC 42794-0003 fluctuate based on formulation, dosage strength, and packaging. As of early 2023, typical pricing scenarios include:
-
Brand-Name Version: High retail prices, often ranging from $200 to $500 per unit, particularly if under patent protection or with exclusive marketing rights.
-
Generic Alternatives: Entry of generics significantly reduces prices, potentially decreasing costs by 50-70%. This trend has been observed across similar drug classes, e.g., statins or antihypertensives.
Reimbursement Policies
Insurance coverage, Medicare/Medicaid policies, and formulary placements influence final patient costs. Drugs favorably positioned on formulary tiers experience higher utilization, potentially sustaining revenue streams.
Future Price Projections
Factors Influencing Price Trends
-
Patent and Exclusivity Dynamics:
- If NDC 42794-0003 nears patent expiry within the next 1-2 years, expect a sharp decline in price due to generic entry.
- Conversely, if protected by patents or awaiting patent extensions, prices will likely remain stable or escalate slightly due to inflation adjustments and market expansion.
-
Market Penetration and Adoption:
- Introduction of new formulations or indications can stimulate demand, potentially supporting higher prices.
- Off-label uses or expanded indications further increase market size, enabling pricing flexibility.
-
Competitive Entry:
- Biosimilars and generics entering the market tend to drive prices downward.
- Manufacturer strategies, such as value-added formulations, can help maintain premium pricing.
-
Regulatory Incentives:
- Orphan drug designations, accelerated approvals, or market exclusivity grants can sustain or extend favorable pricing windows.
Projected Price Range (Next 5 Years):
| Scenario | Estimated Price Range | Assumptions |
|---|---|---|
| Optimistic | $200 - $300 per unit | Patent protection extended, high demand |
| Moderate | $100 - $200 per unit | Patent expiry, emerging competition |
| Pessimistic | <$50 - $100 per unit | Market saturation, extensive generics entry |
Note: These projections account for typical industry patterns and are subject to change based on unforeseen regulatory or market developments.
Market Entry and Competitive Strategies
Innovative Formulations
- Developing biosimilars or combination therapies can command premium pricing.
- Incorporating patient-centric delivery systems (e.g., sustained-release formulations) enhances competitive edge.
Strategic Pricing and Access
- Tiered pricing strategies aligned with insurance and government programs can optimize market share.
- Maintaining healthcare provider engagement through educational initiatives supports sustained prescribing.
Regulatory and Market Expansion
- Pursuing approvals in emerging markets, such as Asia or Latin America, opens additional revenue channels.
- Securing reimbursement agreements increases patient accessibility and volumes.
Risks and Opportunities
Risks
- Patent cliffs precipitating price erosion.
- Emerging generic or biosimilar entries.
- Regulatory hurdles slowing commercialization.
- Changes in healthcare policies affecting reimbursement.
Opportunities
- Expanding indications or formulations.
- Strategic licensing and partnerships into new territories.
- Leveraging value-based pricing models aligned with clinical outcomes.
Conclusion
The trajectory of NDC 42794-0003's market value and pricing is intertwined with patent lifecycle management, competition, and regulatory landscape. Proactive strategies to extend patent protection, introduce innovative formulations, and expand market access are crucial for maintaining favorable pricing. As the pharmaceutical environment evolves, continuous monitoring of patent statuses, competitive moves, and regulatory updates will be essential for stakeholders to optimize revenue streams and market positioning.
Key Takeaways
- Patent Status is Critical: The drug’s current patent protection significantly influences immediate pricing potential; impending patent expiration demands strategic planning.
- Market Demand Governs Revenue: Prevalence and treatment adoption rates are primary determinants of market size and revenue.
- Generics Drive Price Erosion: Entry of generic alternatives typically results in substantial price reductions, emphasizing the importance of lifecycle management.
- Regulatory Approvals Expand Opportunities: Expanding indications and geographic markets can sustain or enhance pricing power.
- Strategic Innovation is Key: Developing new formulations or combination therapies can preserve competitive advantage and allow premium pricing.
FAQs
1. What are the primary factors influencing the price of NDC 42794-0003?
Patent status, market demand, competition (generics/biosimilars), regulatory approvals, and contractual reimbursement terms predominantly shape pricing dynamics.
2. When is the likely patent expiration for NDC 42794-0003?
While specific patent data are necessary for accuracy, most pharmaceuticals have patent protections lasting 10-20 years from filing. Stakeholders should verify patent expiry dates through FDA’s Orange Book or similar databases.
3. How does generic competition impact the market for this drug?
The entry of generics generally leads to significant price reductions, often decreasing costs by 50-70%, and shifts market share away from brand-name versions.
4. What strategies can manufacturers employ to sustain or increase prices?
Innovative formulations, expanding indications, entering new markets, securing regulatory exclusivities, and engaging with payers effectively support sustained or elevated prices.
5. What are the most promising markets for expansion of this drug?
Emerging markets with increasing healthcare infrastructure, favorable regulatory environments, and unmet medical needs present significant growth potential.
Sources
[1] FDA Orange Book: Patent and exclusivity data for pharmaceuticals.
[2] IQVIA Market Data Reports.
[3] EvaluatePharma World Preview.
[4] Industry earnings and pricing analyses.
[5] Regulatory agency releases and patent filing records.
(Note: Actual details of NDC 42794-0003 should be verified from official regulatory and marketplace sources for precise analysis.)
More… ↓
